Using collagenase to treat Dupuytren’s disease: a hypothetical cost benefit analysis

**Background**: Dupuytren’s disease is a disorder of abnormal collagen production that may manifest in the palmar fascia. Treatment options vary according to clinical circumstances but surgical fasciectomy remains the gold standard. Collagenase, an enzyme produced by clostridium histolyticum (CCH),...

Full description

Bibliographic Details
Published in:	Australasian Journal of Plastic Surgery
Main Authors:	Ryan Livingston, Michael Wagels, Alicia Heald
Format:	Article
Language:	English
Published:	Australian Society of Plastic Surgeons 2019-03-01
Online Access:	https://doi.org/10.34239/ajops.v2i1.42

Similar Items

Collagenase injections for Dupuytren’s in Australian public hospitals: a cost analysis
by: Devlin Elliott, et al.
Published: (2019-03-01)

Different collagenase delivery for Dupuytren disease in public hospitals
by: Jessca A Paynter, et al.
Published: (2020-09-01)

Dupuytren’s disease and collagenase: evidence for a paradigm shift in management
by: Jessica A Paynter, et al.
Published: (2018-09-01)

Delayed vascular complication after collagenase injection for Dupuytren disease
by: Jesper Nordenskjöld, et al.
Published: (2023-10-01)

Retraction: Late complications of clinical Clostridium histolyticum collagenase use in Dupuytren's disease.
Published: (2012-01-01)

Determining Risk Factors and Rate of Surgery After Collagenase Injections for Dupuytren Contracture
by: Ryan C. Cha, BA, et al.
Published: (2025-09-01)

Therapy for Dupuytren’s Disease: Collagenase Therapy—A Long-Term Follow-Up Study
by: Nikolaus Wachtel, et al.
Published: (2024-10-01)

Collagenase Management of Multicord Dupuytren’s Disease under Intravenous Sedation: A Prospective Cohort Study
by: Jeremy Wiseman, MBBS, et al.
Published: (2019-02-01)

D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease
by: Elijah G. Bingham, BS, et al.
Published: (2023-04-01)

Collagenase Clostridium histolyticum Versus Needle Fasciotomy for Primary Metacarpophalangeal Dupuytren Contracture
by: Ingi Thor Hauksson, MD, et al.
Published: (2024-12-01)

Clinical Outcomes of Collagenase Injections in Management of Dupuytren Contracture of the Proximal Interphalangeal Joint
by: Craig Dent, MS, et al.
Published: (2024-09-01)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
by: Coleman Stephen, et al.
Published: (2012-04-01)

Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture: systematic review and economic evaluation
by: Miriam Brazzelli, et al.
Published: (2015-10-01)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
by: Bronier Costas, et al.
Published: (2017-08-01)

Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands
by: Jesper Nordenskjöld, et al.
Published: (2019-11-01)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
by: Filippo Boriani, MD, MSc, PhD, et al.
Published: (2022-11-01)

Collagenase Clostridium Histolyticum Versus Percutaneous Needle Fasciotomy for Dupuytren’s Disease: A Systematic Review and Meta-Analysis
by: Ishith Seth, et al.
Published: (2025-02-01)

The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness
by: Michiro Yamamoto, et al.
Published: (2022-05-01)

111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
by: Cyrus S. Steppe, BA, et al.
Published: (2023-05-01)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
by: Kimitoshi Noto, MD, et al.
Published: (2020-01-01)

Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis
by: Stephen B. Camper, MS, PhD, et al.
Published: (2019-04-01)

Therapy for Dupuytren’s Disease (II): Collagenase Therapy vs. Limited Fasciectomy—A Long-Term Comparative Study
by: Nikolaus Wachtel, et al.
Published: (2025-01-01)

CLINICAL RESULTS OF COLLAGENASE TREATMENT FOR DUPUYTREN’S DISEASE: A CASE SERIES STUDY WITH 2-YEARS FOLLOW-UP
by: Morena Anna Basso, et al.
Published: (2023-04-01)

Hand therapy or not following collagenase treatment for Dupuytren’s contracture? Protocol for a randomised controlled trial
by: Terese Aglen, et al.
Published: (2019-08-01)

Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease: A Prospective Cohort Study
by: David Eckerdal, et al.
Published: (2023-02-01)

Treatment of Dupuytren’s contracture with collagenase clostridium histolyticum under clinical practice conditions: ReDUCTo study
by: Haerle, Max, et al.
Published: (2015-08-01)

Collagenase clostridium histolyticum for Dupuytren’s disease: a comprehensive systematic review and comparative analysis against percutaneous needle aponeurotomy and limited fasciectomy
by: Jevan Cevik, et al.
Published: (2025-02-01)

Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease: a systematic review
by: David Eckerdal, et al.
Published: (2024-07-01)

Collagenase injection versus limited fasciectomy surgery to treat Dupuytren’s contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation
by: Joseph Dias, et al.
Published: (2024-12-01)

Dupuytren's disease
by: Rames Mattar Junior
Published: (2008-03-01)

Collagenase injections for the treatment of single cords in cases of Dupuytren’s contracture – a prospective intervention study of long-term experience with Xiapex
by: Fischer, Lisa Maria, et al.
Published: (2017-04-01)

Needle Aponeurotomy Versus Collagenase Injections for Dupuytren Disease: A Review of the Literature and Survey of Patient-Reported Satisfaction, Recurrence, and Complications After Needle Aponeurotomy
by: Joseph A. Buckwalter V, MD, PhD, et al.
Published: (2019-04-01)

Paediatric Dupuytren′s disease
by: Pradeoth Mukundan Korambayil, et al.
Published: (2011-01-01)

Paediatric Dupuytren's disease
by: Pradeoth Mukundan Korambayil, et al.
Published: (2011-09-01)

Epidemiological analysis of patients with Dupuytren's disease
by: Henrique Gonçalves Mansur, et al.

The prevalence of Dupuytren’s disease in patients with diabetes mellitus
by: Sandhya Ganesan, et al.
Published: (2023-07-01)

THE ROLE OF KINETIC METHODS USED IN DUPUYTREN DISEASE
by: Oana Berăriţa, et al.
Published: (2018-10-01)

Letter to the editor regarding ‘Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease: a systematic review’ by Eckerdal et al.
by: Joakim Strömberg
Published: (2025-07-01)

Dupuytren’s contractures
by: Siddeswari S, et al.
Published: (2015-01-01)

Dupuytrens disease–where to from here?
by: David B McCombe
Published: (2019-03-01)